Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations
New Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 45 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 100th Authority meeting dated 05.08.2022.
The said formulations include diabetes medications such as Pure & Cure Healthcare and Cadila Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Torrent Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Exemed Pharma and Cipla's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Bajaj Healthcare and J.B. Chemicals & Pharmaceuticals's Sitagliptin Phosphate and Metformin Hydrochloride Tablets, MSN Labs and Eris Lifesciences's Linagliptin and Metformin Hydrochloride extended-release Tablet.
The fixed price list table further includes Aagya Biotech and German Remedies Pharma's Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets, Micro Labs's Amoxycillin and Potassium Clavulanate Oral Suspension IP., Sirmour Remedies and Mankind Pharma Ltd.'s Diclofenac, Methyl Salicylate & Menthol Gel, Pure and Cure Healthcare and Cadila Pharma's Omeprazole (GR) & Domperidone (SR) Capsules, Acme Generics and Mankind Prime Labs's Gastro-Resistant Esomeprazole and Domperidone Sustained Release Capsule, Pure and Cure Healthcare and Torrent Pharma's Etamsylate & Tranexamic Acid Tablets.
This comes after in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Cyclosporine Eye Drop | Each ml contains: Cyclosporine IP 0.5mg |
1 ml | M/s Indiana Opthalmics / M/s Intas Pharmaceuticals Ltd. | 96.15 |
| 2. | Omeprazole (GR) & Domperidone (SR) Capsules | Each Hard Gelatin Capsule Contains: Omeprazole IP 20mg (As Gastro Resistant Pellets) Domperidone IP 30mg (As Sustained Release Pellets) |
1 Capsule | M/s Pure and Cure Healthcare Pvt. Ltd./M/s Cadila Pharmaceuticals Ltd. | 9.53 |
| 3. | Pantoprazole Dual Release Gastro Resistant Tablets | Each dual-release gastro resistant tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 80mg |
1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Hetero Healthcare Ltd. | 11.16 |
| 4. | Gastro-Resistant Esomeprazole and Domperidone Sustained Release Capsule | Each hard gelatin Capsule Contains: Esomeprazole Magnesium Trihydrate eq. to Esomeprazole IP 40mg (As Gastro-resistant pellets) Domperidone IP 30mg (As sustained release pellets) |
1 Capsule | M/s Acme Generics Private Limited / M/s Mankind Prime Labs Pvt. Ltd. | 11.32 |
| 5. | Amlodipine and Atenolol tablets | Each uncoated tablet contains: Amlodipine Besilate IP eq. to Amlodipine 5mg Atenolol IP 50mg |
1 Tablet | M/s East African (India) Overseas / M/s Softdeal Pharmaceuticals Pvt. Ltd. | 5.21 |
| 6. | Etamsylate & Tranexamic Acid Tablets | Each film coated tablet contains: Etamsylate BP 250mg, Tranexamic Acid IP 250mg |
1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd. | 17.82 |
| 7. | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets | Each uncoated tablet contains:
Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 3.73 |
| 8. | Amoxycillin and Potassium Clavulanate Oral Suspension IP | Each Composite Pack Contains: A & B Each 5ml of reconstituted suspension contains: A. Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg, Potassium Calvulanate IP (as Potassium Clavulanate Diluted IP) eq. to Clavulanic Acid 42.9mg
sterile water for reconstitution of Dry Syrup (as sterile water for Injection IP) |
Per Combi Pack | M/s Micro Labs Limited | 168.43 |
| 9. | Diclofenac, Methyl Salicylate & Menthol Gel | Composition: Diclofenac Diethylamine IP 2.32%w/w (eq. to Diclofenac Sodium 2.00% w/w) Methyl Salicylate IP 10.00%w/w Menthol IP 5.00%w/w |
1 gm | M/s Sirmour Remedies Pvt. Ltd. / M/s Mankind Pharma Ltd. | 3.93 |
| 10. | Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an sustained release form) IP 500mg |
1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 18.67 |
| 11. | Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as sustained release form) IP 1000mg |
1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 20.06 |
| 12. | Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as sustained release form) IP 1000mg |
1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 21.56 |
| 13. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an Extended release form) IP 500mg |
1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 18.00 |
| 14. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 1000mg |
1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 20.00 |
| 15. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as Extended release form) IP 1000mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 20.06 |
| 16. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as Extended release form) IP 500mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 18.67 |
| 17. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 500mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 20.00 |
| 18. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 1000mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd. | 21.00 |
| 19. | Sitagliptin and Metformin Hydrochloride Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg |
1 Tablet | M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd. | 18.34 |
| 20. | Sitagliptin and Metformin Hydrochloride Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 850mg |
1 Tablet | M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd. | 19.26 |
| 21. | Sitagliptin and Metformin Hydrochloride Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg |
1 Tablet | M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd. | 20.02 |
| 22. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an Extended release form) IP 1000mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd. | 20.00 |
| 23. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 500mg |
1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd. | 18.00 |
| 24. | Sitagliptin and Metformin Hydrochloride (Sustained Release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 500 mg (as Sustained Release form) |
1 Tablet | M/s Mascot Health Series Private Limited / M/s Alembic Pharmaceuticals Ltd. | 16.07 |
| 25. | Sitagliptin and Metformin Hydrochloride (Sustained Release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as Sustained Release form) |
1 Tablet | M/s Mascot Health Series Private Limited / M/s Alembic Pharmaceuticals Ltd. | 17.85 |
| 26. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP (as Extended Release form) 1000 mg |
1 Tablet | M/s Intas Pharmaceuticals Ltd. | 21.56 |
| 27. | Sitagliptin and Metformin Hydrochloride (ER) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP (as Extended Release form) 500 mg |
1 Tablet | M/s Intas Pharmaceuticals Ltd. | 18.67 |
| 28. | Sitagliptin and Metformin Hydrochloride (ER) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP (as extended Release form) 1000 mg |
1 Tablet | M/s Intas Pharmaceuticals Ltd. | 20.06 |
| 29. | Sitagliptin and Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP (as extended Release form) 500 mg |
1 Tablet | M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd. | 20.17 |
| 30. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an extended release form) IP 500mg |
1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 18.67 |
| 31. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an extended release form) IP 1000mg |
1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 20.06 |
| 32. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an extended release form) IP 500mg |
1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 20.00 |
| 33. | Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an extended release form) IP 1000mg |
1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 21.56 |
| 34. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg |
1 Tablet | M/s Bajaj Healthcare Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd. | 18.34 |
| 35. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg |
1 Tablet | M/s Bajaj Healthcare Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd. | 20.02 |
| 36. | Purified Freeze- Dried Human Coagulation Factor VIII, Virus Inactivated IP (Immunate) | Composition: Purified Freeze-Dried Human Coagulation Factor VIII, Virus Inactivated IP 1000IU 1 vial with 10ml Sterilized Water for Injection |
Per Pack | M/s Baxalta Bioscience India Pvt. Ltd. | 11606.67 |
| 37. | Linagliptin and Metformin Hydrochloride extended-release Tablet | Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP (as extended release) 1000mg |
1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Eris Lifesciences Limited | 16.37 |
| 38. | Linagliptin and Metformin Hydrochloride extended-release Tablet | Each film coated tablet contains: Linagliptin 5mg Metformin Hydrochloride IP (as extended release) 1000mg |
1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Eris Lifesciences Limited | 25.33 |
| 39. | Acetazolamide Extended-Release Capsules | Each capsule contains: Acetazolamide IP 500mg |
1 Capsule | M/s Sidmak Laboratories (India) Pvt. Ltd. / M/s Sun Pharma Laboratories Limited | 8.15 |
| 40. | Beclomethasone Dipropionate, Clotrimazole & Neomycin Sulphate Cream | Composition: Beclomethasone Dipropionate IP 0.025%w/w, Clotrimazole IP 1.00%w/w, Neomycin Sulphate IP 0.50% w/w |
1 Gram | M/s Pharma Force Lab / M/s Torrent Pharmaceuticals Ltd. | 6.33 |
| 41. | Pantoprazole Dual Release Gastro Resistant Tablets | Each Dual Release Gastro Resistant Tablet Contains: Pantoprazole Sodium Eq. to Pantoprazole 80mg |
1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Limited | 15.49 |
| 42. | Benidipine & Telmisartan Tablets | Each film coated tablet contains: Benidipine Hydrochloride JP 4mg Telmisartan IP 40mg |
1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 12.70 |
| 43. | Benidipine & Telmisartan Tablets | Each film coated tablet contains: Benidipine Hydrochloride JP 4mg Telmisartan IP 80mg |
1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 9.94 |
| 44. | Cilnidipine, Telmisartan & Chlorthalidone Tablets | Each Film Coated Tablet contains: Cilnidipine 10mg Telmisartan 40mg Chlorthalidone 6.25 mg |
1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. | 12.50 |
| 45. | Budesonide & Formoterol Fumarate Respirator Suspension | Each 2ml contains: Budesonide IP 0.5mg Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg |
1 ml | M/s Axa Parenterals Limited / M/s Mankind Pharma Ltd. | 22.75 |
Notice further reads:
For more details, check out the official notice on the official site of NPPA:
https://medicaldialogues.in/pdf_upload/nppa-184257.pdf
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.